Atlas FDA

Acess AFP Reagents on the Access Immunoassay Systems

FDA premarket approval P980041/S043 · decided 2020-05-28

Approval details

PMA number
P980041
Supplement
S043
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Acess AFP Reagents on the Access Immunoassay Systems
Generic name
KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS
Applicant
Beckman Coulter, Inc.
Date received
2019-04-03
Decision date
2020-05-28
Days to decision
421 days
Decision code
APPR
Product code
LOK
Advisory committee
Immunology
Expedited review
No
Location
Brea, CA
Statement
Approval to optimize the metal ion ratios in order to support stable alkaline phosphatase activity in the conjugate diluent used in the Access AFP Reagents.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Access BNP II (K252169)Beckman Coulter, Inc.2026-03-24
Access anti-HBc IgM (K254059)Beckman Coulter, Inc.2026-03-13
Access anti-HBc Total (K253687)Beckman Coulter, Inc.2026-02-19
Access anti-HAV IgM (K251995)Beckman Coulter, Inc.2026-01-27
Access Rubella IgG (K250588)Beckman Coulter, Inc.2025-11-17
iQ200 Series (K252580)Beckman Coulter, Inc.2025-09-10
Access anti-HAV (K243846)Beckman Coulter, Inc.2025-09-09
MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL) (MicroScan) (K243804)Beckman Coulter, Inc.2025-08-20